Astera Labs (ALAB) Price Prediction 2026: Can Scorpio X-Series Push ALAB Stock to $500?

Astera Labs (ALAB) reported second-quarter results on August 4, 2026 that beat consensus on revenue and adjusted earnings. Revenue was $392.4 million, up 104% from a year earlier, and non-GAAP diluted EPS was $0.80 versus a $0.691 estimate in market data. Management guided third-quarter revenue to $540 million to $560 million and non-GAAP EPS to $1.16 to $1.21. The latest completed-session close was $322.78 on August 13, 2026, after a volatile post-report period.

The guidance matters more than the beat. Scorpio X-Series entered volume production and management expects Scorpio to become the largest product family in the third quarter, while non-GAAP gross-margin guidance eased to about 72% from 73.7% in Q2. The central tension is whether a fast AI-fabric revenue ramp can compound into durable multi-customer economics before the market demands proof that margins and customer concentration can withstand the mix shift.

The ALAB stock forecast for 2026 now centers on two competing views:

• The AI-fabric scale-up case: Scorpio X-Series volume production, a Q3 revenue midpoint of $550 million, and a stated path to Scorpio becoming the largest product line can validate a larger connectivity-content opportunity per XPU.
• The execution-and-valuation case: a 72% Q3 gross-margin guide, quarterly concentration risk, and a Street target range of $153 to $500 mean even strong growth may not produce a linear rerating.

This guide breaks down the ALAB stock forecast, 2026 price scenarios, key risks, and Astera Labs' August 4, 2026 earnings release plus aggregate market-data targets retrieved August 14, 2026, alongside how to trade ALAB stock futures on BingX TradFi with USDT collateral.

Top 5 Things for Astera Labs Investors to Know in August 2026

1. Q2 revenue of $392.4 million rose 104% year over year: Revenue also increased 27% from Q1, reflecting growth across AI fabrics and signal conditioning. The result makes the Q3 guide more consequential because it shifts the debate from demand visibility to whether the product ramp can sustain operating leverage.
2. Non-GAAP EPS of $0.80 beat the $0.691 estimate by 15.8%: The reported figure exceeded the market-data estimate by $0.109. The earnings beat supports the operating case, but the next quarter's mix and margin progression matter more for the valuation debate.
3. GAAP gross margin was 73.3%, with Q3 guided near 72%: The one-point step down is not a thesis break by itself. It is a measurable test of whether higher-value fabric products can scale without a sharper-than-guided gross-margin tradeoff.
4. Q3 revenue guidance of $540 million to $560 million implies 40% sequential growth: The midpoint is $550 million. Management tied the inflection to Scorpio X-Series volume production, continued Aries strength, and early Taurus shipments for 800G Ethernet.
5. Street targets span $153 to $500 as of August 14: The $347 spread is a concrete measure of uncertainty around the AI-fabric opportunity. The range should be read as a dispersion of third-party reference points, not a forecast or a price guarantee.
   
   

What Is Astera Labs (ALAB)?

Astera Labs (NASDAQ: ALAB) is a semiconductor connectivity company that builds the hardware and software used to help AI chips, memory, and servers communicate with each other at very high speeds. As AI systems become larger, thousands of components need to exchange data quickly without creating bottlenecks, and Astera Labs focuses on solving that connection problem inside modern data centers.

Its products sit between processors, GPUs, memory, and networking equipment, helping signals travel reliably across complex AI server and rack-scale systems. The portfolio includes PCIe retimers, fabric switches, Ethernet connectivity products, and CXL memory solutions, supported by COSMOS software for system monitoring and validation. In Q2 2026, management said Aries reached record quarterly revenue and PCIe 6.0 products accounted for more than half of company revenue, showing how closely Astera Labs is tied to the buildout of next-generation AI infrastructure.

Astera Labs (ALAB) Q2 2026 Earnings: Scorpio Production Reset the Debate

1. Revenue growth accelerated with the product transition. Q2 revenue of $392.4 million was up 27% sequentially and 104% year over year. Management attributed the strength to AI fabrics and signal conditioning, with Aries at a quarterly record.
2. PCIe 6.0 became a majority revenue contributor. Management said PCIe 6.0 products represented more than 50% of Q2 revenue, up from one-third in Q1. That mix demonstrates deployment progress, although it does not eliminate the risk of a changing gross-margin profile.
3. Operating leverage improved before the next ramp. Non-GAAP operating margin reached 39.1%, up from 36.2% in Q1. The Q3 operating-margin outlook of about 43% is therefore an explicit execution marker for the scale-up thesis.
4. Scorpio X-Series moved into volume production. The company expects Scorpio to become its largest product family in Q3, one quarter ahead of its prior expectation. This is the operating milestone behind the Q3 revenue midpoint of $550 million.
5. The Q3 guide includes a measurable margin tradeoff. Management guided non-GAAP gross margin to about 72%, compared with 73.7% in Q2. Investors therefore need to assess gross-profit dollars and customer breadth, not revenue growth alone.

Read More: Astera Labs (ALAB) Q2 2026 Earnings Overview: AI Chip Growth Fails to Offset 72% Margin Outlook and an 11.96% Selloff

Astera Labs Q2 2026 Financial and Consensus Profile: Revenue, EPS and Margins

Astera Labs' Q2 print showed strong revenue acceleration and an earnings beat alongside a Q3 gross-margin guide that puts product-mix execution at the center of the next debate.

For context, Q1 2026 revenue was $308.4 million, up 93% year over year. The Q2 release also reported GAAP operating income of $89.2 million and GAAP net income of $153.1 million. The company said its Q3 outlook assumes Scorpio X-Series production scaling, continued Aries momentum, and pre-production Taurus shipments. No full-year guidance was disclosed in the August 4 release.

Astera Labs (ALAB) 2026 Investment Outlook: $500 Bull Case vs. $153 Bear Case

Astera Labs' outlook for the rest of 2026 depends on whether Scorpio X-Series volume production converts Q3 guidance into repeatable multi-product revenue and operating leverage before mix, concentration, or valuation pressure changes the market's expectations.

The Bull Case: Scorpio X-Series Execution Pushes ALAB Toward $500

The bull case starts with the Q2 operating proof. Revenue grew 104% year over year, PCIe 6.0 represented more than half of revenue, and non-GAAP operating margin reached 39.1%. If Scorpio becomes the largest product family in Q3 as management expects, the company can demonstrate that the AI-fabric business is expanding beyond a single legacy signal-conditioning cycle.

This outcome requires the Q3 revenue midpoint of $550 million to arrive with the guided margin profile intact, while follow-on customer ramps validate the broader design-win pipeline. RBC Capital raised its target to $500 from $425 on August 5 while maintaining Outperform, which is third-party context rather than an Astera Labs forecast. A visible confirmation point is management's ability to sustain fabric production and show that gross-profit dollars continue to scale despite the 72% Q3 gross-margin guide.

The Base Case: Growth and Valuation Tension Keeps ALAB Between $322.78 and $372.27

The base case allows revenue momentum to continue without assuming an immediate valuation expansion. Q3 guidance implies a sharp sequential step-up, but the company is moving through a product-mix transition and is guiding gross margin lower than Q2. That combination can support growth while keeping investors focused on the durability of earnings quality.

The base range uses the August 13 completed-session close and the aggregate consensus reference retrieved August 14. It is an editorial scenario, not a technical support-and-resistance claim. Consolidation would be consistent with continued execution but incomplete evidence on customer breadth, fabric economics, and the pace of future optical and custom-solution revenue.

The Bear Case: A Slower Fabric Ramp Pulls ALAB Toward $153

The bear case does not require AI infrastructure demand to collapse. It requires Scorpio X-Series revenue, margin conversion, or follow-on customer adoption to fall short of the expectations implied by the Q3 guide and the stock's volatile rerating. A high-growth semiconductor supplier can still face a sharp valuation reset when the next revenue step is delayed.

The observable trigger would be a weaker-than-expected fabric ramp, a more material gross-margin decline, or narrower demand across the portfolio. Those outcomes could reduce confidence in the path from initial volume production to recurring multi-customer revenue. The $153 reference is the aggregate Street low retrieved August 14, 2026, not an article prediction.

ALAB Stock Price Forecasts for 2026 By Wall Street Analysts

Seven dated named analyst actions now frame the external target range. They span $335 to $500 and remain third-party views, not Astera Labs forecasts or editorial scenarios. The spread reflects different assessments of Scorpio X-Series execution, AI-connectivity demand and valuation after Q2.

How to Trade Astera Labs (ALAB) Stock on BingX

Navigate the volatility of Astera Labs' earnings cycle using BingX TradFi and BingX AI tools. ALAB is available through the verified ALAB-USDT perpetual futures contract, which is a derivative rather than ownership of the underlying share and carries funding and liquidation risk.

Step 1: Access BingX TradFi.Sign up, complete applicable KYC and security controls, then navigate to the TradFi section.

Step 2: Select Astera Labs (ALAB). Search for and select the ALAB-USDT perpetual futures contract.

Step 3: Choose your direction. A long thesis depends on Scorpio X-Series production, Q3 revenue delivery, and operating leverage remaining on track. A short thesis depends on a weaker fabric ramp, lower gross-margin conversion, or reduced confidence in customer breadth.

Step 4: Select leverage and margin mode. Choose Isolated or Cross-Margin based on risk tolerance. ALAB showed a 94.03% YTD gain through August 13, 2026 on Google Finance, so conservative leverage and clear position sizing are important.

Step 5: Execute strict risk protocols. Set Take-Profit and Stop-Loss (TP/SL) levels before or immediately after entry. ALAB can react quickly to earnings, guidance, AI-infrastructure demand, product-ramp disclosures, and customer concentration signals.

Top 5 Risks to Watch for Astera Labs Investors in 2026

1. Gross-margin pressure could limit operating leverage: Q3 gross-margin guidance is around 72%, below Q2’s 73.3% GAAP and 73.7% non-GAAP levels. Watch whether product mix and faster fabric growth continue to pressure margins.
2. Scorpio needs to become a durable revenue driver: Management expects Scorpio to become Astera Labs’ largest product family in Q3. Watch whether production ramps translate into repeat orders and broader customer deployment.
3. Rapid growth increases working-capital demands: Astera Labs ended Q2 with $1.25 billion in cash and securities, but inventory reached $113.8 million and receivables $192.5 million. Watch inventory growth, collections, and supply coordination as revenue scales.
4. PCIe 6.0 concentration raises platform-timing risk: PCIe 6.0 products accounted for more than half of Q2 revenue. Watch AI server deployment schedules and customer platform transitions, since delays could create sharper quarterly swings.
5. Valuation expectations remain widely dispersed: Street targets range from $153 to $500, showing how differently analysts view Astera Labs’ growth and earnings potential. Watch whether revenue growth, margins, and customer diversification provide enough evidence to support the higher end of that range.

Final Thoughts: Should You Invest in Astera Labs in 2026?

Following its August 4, 2026 report, Astera Labs combines a fast AI-connectivity revenue ramp with clear operating leverage and a substantial Q3 guide. What remains uncertain is whether Scorpio X-Series can turn that near-term inflection into broad, repeatable economics as the product mix changes.

The bull case is that volume production, continued Aries demand, and new customer deployments validate a larger fabric opportunity, keeping the $500 Street high in view. The bear case is that ramp timing, margin conversion, or concentration evidence disappoints, making the $153 Street low more relevant. More cautious traders may wait for Q3 execution evidence rather than treating the target range as a recommendation.

Risk Reminder: Trading and investing in equities like ALAB involves a high risk of capital loss. Astera Labs is exposed to semiconductor-cycle volatility, AI-infrastructure demand, customer concentration, product-ramp execution, margin mix, and valuation changes, any of which can move the stock independently of its earnings. Conduct independent research before allocating capital.

Related Reading

1. Top AI Server Stocks to Buy in 2026: Rack-Scale Systems, GPU Servers, and AI Servers Infrastructure
2. Top 10 AI Infrastructure Stocks to Buy in 2026: Chip Manufacturing and Design Leaders
3. Coherent (COHR) Stock Price Prediction 2026: Can the AI Optics King Break $460 After Hitting $440?
4. Credo Technology (CRDO) Price Prediction 2026: $300 AEC Hyper-Ramp or Premium Valuation Speedbump?
5. Lumentum Stock Forecast 2026: Can AI Optics Boom, AI Data Center Supercycle Drive LITE Above $1,200?
6. AAOI Stock Prediction 2026: $260 Photonics Boom or Dilution Trap?